Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Hmm? Hehehe!

$FSD Pharma(HUGE.US)$ Is coming after $Safety Shot(SHOT.US)$  I do believe?  (((((.      HUGE Biopharma Australia, a subsidiary of biopharma company FSD Pharma Inc. (NASDAQ:HUGE), has agreed with clinical research organization Ingenu CRO to conduct a cross-over clinical study on a proprietary licensed beverage targeting alcohol metabolization in intoxicated states.
Made up of natural ingredients, vitamins and minerals, UNBUZZD is believed to help with liver and brain function to quickly relieve individuals from the effects of alcohol consumption.
The randomized, double-blind, placebo-controlled trial (METAL-1 TRIAL) will assess the safety and efficacy of unbuzzd in healthy volunteers in an induced state of alcohol intoxication, an important step "to further verify that the effects of drinking unbuzzd helps a person sober up faster from the effects of alcohol."
FSD Pharma's novel dietary supplement product is defined as "a fortified oral liquid formula that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism and accelerates the rate of alcohol metabolism in the body, allowing a person to sober up faster."
CEO and co-founder Zeeshan Saeed says the company's R&D team "has worked tirelessly over the past year to accumulate science-based information to design the unbuzzd recreational alcohol use formulation."
In this sense, the clinical trial is a relevant next step to delivering science-based evidence to confirm what the FSD Pharma team believes it has discovered. "A discovery which could potentially change the rate at which we metabolize alcohol in the body, or in simple terms sober up faster," Saeed added. )))))
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
6
Translate
Report
6786 Views
Comment
Sign in to post a comment
1775Followers
28Following
21KVisitors
Follow